CIK 0000946644 · Non-accelerated filer<br>Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 520845822
- Phone
- 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- 8-K Event Other events
- 4 Grant or award Director acquired 25,797 shares (grant or award)
- 4 Grant or award Director acquired 25,797 shares (grant or award)
- S-1/A Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1 Offering Registration Statement
- 4 Open-market buy CEO & President bought 20,000 shares at $0.21 ($4,240)
- 4 Grant or award Director acquired 27,412 shares (grant or award)
- 4 Grant or award Director acquired 27,412 shares (grant or award)
- 4 Grant or award Director acquired 8,768 shares (grant or award)
- 4 Grant or award Director acquired 26,305 shares (grant or award)
- 4 Grant or award Director acquired 26,305 shares (grant or award)
- 8-K Event Executive or director change
- 3 Insider Initial Statement of Ownership
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Shareholder vote results
- 4 Open-market sale Director sold 4,580 shares at $0.19 ($884)
- 4 Open-market buy CEO & President bought 22,727 shares at $0.21 ($4,682)
- 8-K Event Delisting notice · Other events
Page 8 of 82 · 1,637 filings